Identity
- Security key
- 11957
- Ticker
- ASMB
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2010-12-17
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ASMB
Detail
Enriched 2026-08-14 20:47
- Market cap
- $536,254,785
- Shares outstanding (class)
- 15,892,608
- Shares outstanding (weighted)
- 19,817,250
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 73
- Location
- SOUTH SAN FRANCISCO, CA
- Homepage
- https://www.assemblybio.com
- Description
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.